Recently selected Food and Drug Administration chief lawyer, Hilary K. Perkins, has resigned from the job, according to a ...

A recall has been issued for Zaarah Herbals powders after an investigation in Connecticut found significantly elevated levels ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury ...

The US Food and Drug Administration’s top lawyer resigned on Thursday, two days after her appointment was announced, the agency posted on the social media site X. Before serving as the FDA’s chief ...

To read more letters to the editor, go to oregonlive.com/opinion.

The Girl Scouts of the USA is the focus of a class action lawsuit over its cookies. The organization stands by the products, ...

Authorities in South Carolina arrested 25 people, including five fugitives and three undocumented immigrants during "Operation ICE Storm." ...

The Company is planning to announce interim data from its ongoing Halneuron ® Phase 2b chemotherapy induced neuropathic pain ("CINP”) trial in Q4 2025 ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- ...

Senate Health, Education, Labor, and Pensions Committee will consider Dr. Jayanta Bhattacharya for NIH Director and Dr. Marty Makary for FDA Director.